Blog Book Chapters Case Studies Papers Patents Presentations Thought Leaders Webinars Whitepapers

2020

Process for the preparation of bromodomain inhibitor

WO 2020023438

By: Jonathan Moseley and Antonio Ruda et al.

2017

Combined photo and chemical sintering of a nano-conductive particles deposition layer

WO 2017011150

By: Joseph Renny et al.

2016

Process for the preparation of a stereospecific form of flurbiprofen, or a pharmaceutically acceptable salt

WO 2016/110708

By: CatSci et al.

2014

Process for the removal and return of a catalyst to a liquid phase medium

WO 2014/083109

By: Ed Turp et al.

2011

1H-Pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors and their preparation and use for the treatment of protein kinase-mediated diseases

WO 2011/094273

By: Guy Brenchley et al.

2010

Tri-cyclic pyrazolopyridine kinase inhibitors

WO 2010/011772

By: Guy Brenchley et al.

2010

Preparation of pyrazine derivative as glucokinase modulator

WO 2010/092386

By: Sharon Bowden et al.

2009

Thiophene-carboxamides useful as inhibitors of protein kinases

US 20090286840

By: Guy Brenchley et al.

2009

Preparation of [1H-pyrazolo[3,4-b]pyridin-4-yl]phenyl or pyridin-2-yl derivatives as protein kinase C-theta inhibitors

WO 2009/073300

By: Guy Brenchley et al.

2008

Preparation of 5-cyano-4-(pyrrolo[2,3-b]pyridin-3-yl)pyrimidines as polo-like kinase (PLK) inhibitors

WO 2008/079346

By: Guy Brenchley et al.